Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC).

Xicola RM, Bontu S, Doyle BJ, Rawson J, Garre P, Lee E, de la Hoya M, Bessa X, Clofent J, Bujanda L, Balaguer F, Castellví-Bel S, Alenda C, Jover R, Ruiz-Ponte C, Syngal S, Andreu M, Carracedo A, Castells A, Newcomb PA, Lindor N, Potter JD, Baron JA, Ellis NA, Caldes T, LLor X.

Carcinogenesis. 2016 Aug;37(8):751-8. doi: 10.1093/carcin/bgw064.

PMID:
27234654
2.

Genetic predisposition to colorectal cancer: where we stand and future perspectives.

Valle L.

World J Gastroenterol. 2014 Aug 7;20(29):9828-49. doi: 10.3748/wjg.v20.i29.9828. Review.

3.

Little evidence for association between the TGFBR1*6A variant and colorectal cancer: a family-based association study on non-syndromic family members from Australia and Spain.

Ross JP, Lockett LJ, Tabor B, Saunders IW, Young GP, Macrae F, Blanco I, Capella G, Brown GS, Lockett TJ, Hannan GN.

BMC Cancer. 2014 Jul 1;14:475. doi: 10.1186/1471-2407-14-475.

4.

Linkage analysis in familial non-Lynch syndrome colorectal cancer families from Sweden.

Kontham V, von Holst S, Lindblom A.

PLoS One. 2013 Dec 11;8(12):e83936. doi: 10.1371/journal.pone.0083936.

5.

Familial colorectal cancer, beyond Lynch syndrome.

Stoffel EM, Kastrinos F.

Clin Gastroenterol Hepatol. 2014 Jul;12(7):1059-68. doi: 10.1016/j.cgh.2013.08.015. Review.

6.

Identification of novel variants in colorectal cancer families by high-throughput exome sequencing.

DeRycke MS, Gunawardena SR, Middha S, Asmann YW, Schaid DJ, McDonnell SK, Riska SM, Eckloff BW, Cunningham JM, Fridley BL, Serie DJ, Bamlet WR, Cicek MS, Jenkins MA, Duggan DJ, Buchanan D, Clendenning M, Haile RW, Woods MO, Gallinger SN, Casey G, Potter JD, Newcomb PA, Le Marchand L, Lindor NM, Thibodeau SN, Goode EL.

Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1239-51. doi: 10.1158/1055-9965.EPI-12-1226.

7.

Aberrant O-glycosylation and anti-glycan antibodies in an autoimmune disease IgA nephropathy and breast adenocarcinoma.

Stuchlová Horynová M, Raška M, Clausen H, Novak J.

Cell Mol Life Sci. 2013 Mar;70(5):829-39. doi: 10.1007/s00018-012-1082-6. Review.

8.

A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24.

Higginbotham KS, Breyer JP, McReynolds KM, Bradley KM, Schuyler PA, Plummer WD, Freudenthal ME, Trentham-Dietz A, Newcomb PA, Parl FF, Sanders ME, Page DL, Egan KM, Dupont WD, Smith JR.

Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1565-73. doi: 10.1158/1055-9965.EPI-12-0386.

9.

Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22.

Cicek MS, Cunningham JM, Fridley BL, Serie DJ, Bamlet WR, Diergaarde B, Haile RW, Le Marchand L, Krontiris TG, Younghusband HB, Gallinger S, Newcomb PA, Hopper JL, Jenkins MA, Casey G, Schumacher F, Chen Z, DeRycke MS, Templeton AS, Winship I, Green RC, Green JS, Macrae FA, Parry S, Young GP, Young JP, Buchanan D, Thomas DC, Bishop DT, Lindor NM, Thibodeau SN, Potter JD, Goode EL; Colon CFR..

PLoS One. 2012;7(5):e38175. doi: 10.1371/journal.pone.0038175. Erratum in: PLoS One. 2012;7(11). doi:10.1371/annotation/1ba2f5e3-8aef-4a12-909b-23f95a889325.

10.

Debate about TGFBR1 and the susceptibility to colorectal cancer.

Valle L.

World J Gastrointest Oncol. 2012 Jan 15;4(1):1-8. doi: 10.4251/wjgo.v4.i1.1.

11.

Evidence of linkage to chromosomes 10p15.3-p15.1, 14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families.

Saunders IW, Ross J, Macrae F, Young GP, Blanco I, Brohede J, Brown G, Brookes D, Lockett T, Molloy PL, Moreno V, Capella G, Hannan GN.

Eur J Hum Genet. 2012 Jan;20(1):91-6. doi: 10.1038/ejhg.2011.149.

12.

A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22.

Abulí A, Fernández-Rozadilla C, Giráldez MD, Muñoz J, Gonzalo V, Bessa X, Bujanda L, Reñé JM, Lanas A, García AM, Saló J, Argüello L, Vilella A, Carreño R, Jover R, Xicola RM, Llor X, Carvajal-Carmona L, Tomlinson IP, Kerr DJ, Houlston RS, Piqué JM, Carracedo A, Castells A, Andreu M, Ruiz-Ponte C, Castellví-Bel S; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association..

Br J Cancer. 2011 Sep 6;105(6):870-5. doi: 10.1038/bjc.2011.296.

13.

Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome).

Roberts A, Nancarrow D, Clendenning M, Buchanan DD, Jenkins MA, Duggan D, Taverna D, McKeone D, Walters R, Walsh MD, Young BW, Jass JR, Rosty C, Gattas M, Pelzer E, Hopper JL, Goldblatt J, George J, Suthers GK, Phillips K, Parry S, Woodall S, Arnold J, Tucker K, Muir A, Drini M, Macrae F, Newcomb P, Potter JD, Pavluk E, Lindblom A, Young JP.

Fam Cancer. 2011 Jun;10(2):245-54. doi: 10.1007/s10689-010-9408-8.

Items per page

Supplemental Content

Support Center